| Authors: |
Saj F; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Namayanja FK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borad MJ; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Kelley RK; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA., Goyal L; Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, California, USA., Azad NS; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bachini M; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Lindsey S; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Valle JW; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Fashoyin-Aje LA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Javle M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
